+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • November 2022
  • 175 Pages
  • Global
From
Angina Pectoris Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Angina Pectoris Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 100 Pages
  • Global
From
Red Biotechnology Market 2024-2028 - Product Thumbnail Image

Red Biotechnology Market 2024-2028

  • Report
  • December 2023
  • 166 Pages
  • Global
From
Polyarticular Juvenile Idiopathic Arthritis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Polyarticular Juvenile Idiopathic Arthritis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 87 Pages
  • Global
From
Atopic Dermatitis Market By Drug Class, By Mode Of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Atopic Dermatitis Market By Drug Class, By Mode Of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • September 2022
  • 293 Pages
  • Global
From
Macular Edema Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Macular Edema Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 99 Pages
  • Global
From
LAMEA Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Middle East, Africa
From
Asia Pacific Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Asia Pacific
From
Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030 - Product Thumbnail Image

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

  • Report
  • January 2019
  • 230 Pages
  • Global
From
North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 111 Pages
  • North America
From
Europe Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Europe
From
Rheumatoid Arthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Rheumatoid Arthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 91 Pages
  • Global
From
Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 700 Pages
  • Global
From
Rheumatoid Arthritis Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 118 Pages
  • Global
From
LAMEA Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 82 Pages
  • Africa, Middle East
From
Europe Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 82 Pages
  • Europe
From
Asia Pacific Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 82 Pages
  • Asia Pacific
From
North America Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 74 Pages
  • North America
From
Macular Degeneration Treatment Market Global Market Report 2022 - Product Thumbnail Image

Macular Degeneration Treatment Market Global Market Report 2022

  • Report
  • June 2022
  • 175 Pages
  • Global
From
Bispecific Antibodies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Bispecific Antibodies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • December 2021
  • 99 Pages
  • Global
From
Loading Indicator